Breast Cancer
News
Breast milk liquid biopsy under study for early-stage breast cancer detection
Just like taking a small blood sample from newborns in a heel-prick test to rule out metabolic diseases, milk samples could be taken from women...
News
Can a Mediterranean diet reduce breast cancer recurrence?
A growing body of evidence suggests that a better dietary quality may improve survival among patients with breast cancer, but whether diet impacts...
News
FDA OKs capivasertib for certain advanced breast cancers
The FDA also approved a companion diagnostic device, the FoundationOne CDx assay, to identify patients who are eligible for treatment with...
News
False-positive mammography results and risk for cancer death
The analysis provides clues about which patients with false-positive mammography results will go on to develop breast cancer and “can be used to...
Conference Recap
Highlights in Early Breast Cancer From ESMO 2023
Highlights in early breast cancer from ESMO 2023 include 5-year results from KEYNOTE-522 in TNBC, pCR benefits in ER+/HER2-, and a genomic risk...
Conference Coverage
Particulate pollution increases the risk for breast cancer
“There is now strong epidemiological and biological evidence for the link between PM2.5 particulate exposure and cancer ...”
News
Low vitamin D linked to paclitaxel-induced peripheral neuropathy
These results also “suggest that vitamin D supplementation in patients with lower levels of vitamin D may reduce peripheral neuropathy ...”
Conference Coverage
Dato-DXd trumps chemo in advanced HR+/HER2– breast cancer
The antibody-drug conjugate datopotamab deruxtecan had better efficacy and safety than chemotherapy for patients with endocrine-resistant...
Conference Coverage
The sobering facts about alcohol and cancer
An ESMO session highlights the well-known links between alcohol consumption and cancer and calls on healthcare professionals to do more to raise...
Conference Coverage
ICIs improve pCR rates in early ER+/HER2– breast cancer
Nivolumab and pembrolizumab boosted pathologic complete response rates when added to neoadjuvant and adjuvant therapy in patients with high-risk...